Menu
Back to User profile » Dr Dimitris Petridis
Papers published by Dr Dimitris Petridis:
Reduction of exercise capacity in sarcoidosis in relation to disease severity
Kallianos A, Zarogoulidis P, Ampatzoglou F, Trakada G, Gialafos E, Pitsiou G, Pataka A, Veletza L, Zarogoulidis K, Hohenforst-Schmidt W, Petridis D, Kioumis I, Rapti A
Patient Preference and Adherence 2015, 9:1179-1188
Published Date: 18 August 2015
Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients
Porpodis K, Domvri K, Zarogoulidis P, Petridis D, Tsirgogianni K, Papaioannou A, Hatzizisi O, Kioumis I, Liaka A, Kikidaki V, Lampaki S, Organtzis J, Zarogoulidis K
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1123-1128
Published Date: 15 June 2015
Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
Pitsiou G, Zarogoulidis P, Petridis D, Kioumis I, Lampaki S, Organtzis J, Porpodis K, Papaiwannou A, Tsiouda T, Hohenforst-Schmidt W, Kakolyris S, Syrigos K, Huang H, Li Q, Turner JF, Zarogoulidis K
Drug Design, Development and Therapy 2014, 8:1753-1763
Published Date: 7 October 2014
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
Zarogoulidis P, Kioumis I, Lampaki S, Organtzis J, Porpodis K, Spyratos D, Pitsiou G, Petridis D, Pataka A, Huang H, Li Q, Yarmus L, Hohenforst-Schmidt W, Pezirkianidis N, Zarogoulidis K
Drug Design, Development and Therapy 2014, 8:1065-1072
Published Date: 12 August 2014
Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach
Petridis D, Zarogoulidis P, Kallianos A, Kioumis I, Trakada G, Spyratos D, Papaiwannou A, Porpodis K, Huang H, Rapti A, Hohenforst-Schmidt W, Zarogoulidis K
Therapeutics and Clinical Risk Management 2014, 10:77-86
Published Date: 7 February 2014